304 related articles for article (PubMed ID: 35640803)
21. Extracellular Vesicles as Natural Nanosized Delivery Systems for Small-Molecule Drugs and Genetic Material: Steps towards the Future Nanomedicines.
Kotmakçı M; Bozok Çetintaş V
J Pharm Pharm Sci; 2015; 18(3):396-413. PubMed ID: 26517135
[TBL] [Abstract][Full Text] [Related]
22. Methods, Mechanisms, and Application Prospects for Enhancing Extracellular Vesicle Uptake.
Xu YP; Jiang T; Yang XF; Chen ZB
Curr Med Sci; 2024 Apr; 44(2):247-260. PubMed ID: 38622425
[TBL] [Abstract][Full Text] [Related]
23. Small extracellular vesicle loading systems in cancer therapy: Current status and the way forward.
Zhang YF; Shi JB; Li C
Cytotherapy; 2019 Nov; 21(11):1122-1136. PubMed ID: 31699595
[TBL] [Abstract][Full Text] [Related]
24. Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs).
Ke W; Afonin KA
Adv Drug Deliv Rev; 2021 Sep; 176():113835. PubMed ID: 34144087
[TBL] [Abstract][Full Text] [Related]
25. Extracellular vesicle mimetics: Novel alternatives to extracellular vesicle-based theranostics, drug delivery, and vaccines.
Kim OY; Lee J; Gho YS
Semin Cell Dev Biol; 2017 Jul; 67():74-82. PubMed ID: 27916566
[TBL] [Abstract][Full Text] [Related]
26. Approaches to surface engineering of extracellular vesicles.
Richter M; Vader P; Fuhrmann G
Adv Drug Deliv Rev; 2021 Jun; 173():416-426. PubMed ID: 33831479
[TBL] [Abstract][Full Text] [Related]
27. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
[TBL] [Abstract][Full Text] [Related]
28. Exosomes as drug delivery systems: A brief overview and progress update.
Patil SM; Sawant SS; Kunda NK
Eur J Pharm Biopharm; 2020 Sep; 154():259-269. PubMed ID: 32717385
[TBL] [Abstract][Full Text] [Related]
29. CRISPR delivery with extracellular vesicles: Promises and challenges.
Berggreen AH; Petersen JL; Lin L; Benabdellah K; Luo Y
J Extracell Biol; 2023 Sep; 2(9):e111. PubMed ID: 38938376
[TBL] [Abstract][Full Text] [Related]
30. Exosome-Based Drug Delivery: Translation from Bench to Clinic.
Koh HB; Kim HJ; Kang SW; Yoo TH
Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631256
[TBL] [Abstract][Full Text] [Related]
31. Synthetic nucleic acids delivered by exosomes: a potential therapeutic for generelated metabolic brain diseases.
Liu R; Liu J; Ji X; Liu Y
Metab Brain Dis; 2013 Dec; 28(4):551-62. PubMed ID: 24022398
[TBL] [Abstract][Full Text] [Related]
32. Extracellular vesicles for improved tumor accumulation and penetration.
Bie N; Yong T; Wei Z; Gan L; Yang X
Adv Drug Deliv Rev; 2022 Sep; 188():114450. PubMed ID: 35841955
[TBL] [Abstract][Full Text] [Related]
33. Synthetic and Biological Vesicular Nano-Carriers Designed for Gene Delivery.
Soltani F; Parhiz H; Mokhtarzadeh A; Ramezani M
Curr Pharm Des; 2015; 21(42):6214-35. PubMed ID: 26503143
[TBL] [Abstract][Full Text] [Related]
34. Recent Advances in CRISPR/Cas9 Delivery Strategies.
Yip BH
Biomolecules; 2020 May; 10(6):. PubMed ID: 32486234
[TBL] [Abstract][Full Text] [Related]
35. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
36. Exosomal targeting and its potential clinical application.
He J; Ren W; Wang W; Han W; Jiang L; Zhang D; Guo M
Drug Deliv Transl Res; 2022 Oct; 12(10):2385-2402. PubMed ID: 34973131
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic Potential of Engineered Extracellular Vesicles.
Mentkowski KI; Snitzer JD; Rusnak S; Lang JK
AAPS J; 2018 Mar; 20(3):50. PubMed ID: 29546642
[TBL] [Abstract][Full Text] [Related]
38. Extracellular vesicles in pharmacology: Novel approaches in diagnostics and therapy.
Quadri Z; Elsherbini A; Bieberich E
Pharmacol Res; 2022 Jan; 175():105980. PubMed ID: 34863822
[TBL] [Abstract][Full Text] [Related]
39. Strategies for Engineering Exosomes and Their Applications in Drug Delivery.
Zhu M; Li S; Li S; Wang H; Xu J; Wang Y; Liang G
J Biomed Nanotechnol; 2021 Dec; 17(12):2271-2297. PubMed ID: 34974854
[TBL] [Abstract][Full Text] [Related]
40. Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies.
Xu M; Feng T; Liu B; Qiu F; Xu Y; Zhao Y; Zheng Y
Theranostics; 2021; 11(18):8926-8944. PubMed ID: 34522219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
